Journals / Türk Kardiyoloji Derneği Arşivi / 2013 / Cilt: 41 - Sayı: 7

Relationship between D-dimer and systemic embolism in patients with infective endocarditis

Enfektif endokarditli hastalarda D-dimer düzeyinin sistemik emboliyle ilişkisi

Pages
589–594
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to determine the predictive value of DD levels for clinically silent systemic embolism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to investigate the value of plasma D-dimer (DD) levels for predicting systemic embo- lism in patients with infective endocarditis (IE).
📊
Key Findings & Data:Study design: A total of 42 patients (mean age: 46±16 years; 78% males) with IE were included.
💡
Conclusion & Impact:Further studies are needed to determine the predictive value of DD levels for clinically silent systemic embolism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to investigate the value of plasma D-dimer (DD) levels for predicting systemic embo- lism in patients with infective endocarditis (IE). Study design: A total of 42 patients (mean age: 46±16 years; 78% males) with IE were included. Clinical, laboratory and echocardiographic findings of the patients were evaluated. Results: Increased plasma DD levels were determined in 13 patients with systemic embolism (p=0.016). Moreover, when patients were divided in two groups as DD >500 ng/dl and DD 500 ng/dl group (p=0.036). Receiver operating characteristics (ROC) curve analysis was performed to detect the best cut-off value of DD in the prediction of systemic embolism. DD >425 ng/dl yielded an area under the curve (AUC) value of 0.735 (95% CI 0.560-0.909, p=0.016). DD >425 ng/dl demonstrated a sensitivity of 77% and specificity of 62% for the prediction of clinical embolism. Hematocrit (r=-0.31, p=0.045), platelet count (r=-0.40, p=0.009), albumin (r=-0.37, p=0.026), and globulin (r=0.38, p=0.028) levels were correlated with DD levels. Conclusion: Plasma DD levels are increased in patients with IE who suffered from clinically significant systemic embolism. Further studies are needed to determine the predictive value of DD levels for clinically silent systemic embolism.

Özet

Amaç: Çalışmanın amacı, enfektif endokarditli (EE) hastalarda plazma D-dimer (DD) düzeylerinin klinik bulgu veren sistemik embolik olayları öngörmedeki değerini araştırmaktır. Çalışma planı: Çalışmaya EE tanısı konulan 42 (ortalama yaş: 45±16, %78i erkek) hasta dahil edildi. Hastaların klinik, laboratuvar ve ekokardiyografik bulguları değerlendirildi. Bulgular: Sistemik emboli olan 13 hastada plazma DD düzeyi, olmayanlara göre daha yüksek tespit edildi (p=0.016). Ayrıca hastalar DD >500 ng/dL ve 500 ng/dL olan grupta klinik emboli oranı daha yüksek saptandı (p=0.036). ROC eğrisi (receiver operating curve) analizinde DD >425 ng/dL değerinde eğri altında kalan alan 0.735 olarak hesaplandı (%95 GA 0.560-0.909, p=0.016). DD >425 ng/dL değeri, %77 duyarlılık ve %62 özgüllükle klinik emboliyi öngörmektedir. Hematokrit (r=-0.31, p=0.045), trombosit (r=-0.40, p=0.009), albümin (r=-0.37, p=0.026) ve globülin (r=0.38, p=0.028) düzeyleri ile DD düzeyi arasında anlamlı korelasyon saptandı. Sonuç: Enfektif endokarditli hastalardan embolik olay gelişenlerde DD seviyeleri yüksek bulundu. Plazma DD düzeylerinin sessiz embolileri öngörmedeki yerini belirlemek için yeni çalışmalara ihtiyaç vardır.

🔖

Cite This Article

OMAYGENÇ, O., ÖZVEREN, O., BAKAL, R. B., AKGÜN, T., AKPINAR, S. H., ÖZDEMİR, N., KAHVECİ, G., KARAKOYUN, S. (2022). Relationship between D-dimer and systemic embolism in patients with infective endocarditis. Türk Kardiyoloji Derneği Arşivi, Cilt: 41 - Sayı: 7, 589–594. https://ajindex.com/articles/632885

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Kario K, Matsuo T, Kobayashi H. Which factors affect high D-dimer levels in the elderly? Thromb Res 1991;62:501-8
  2. Hager K, Platt D. Fibrin degeneration product concentrations (D-dimers) in the course of ageing. Gerontology 1995;41:159-65 3. Chapman CS, Akhtar N, Campbell S, Miles K, O’Connor J, Mitchell VE. The use of D-Dimer assay by enzyme immuno- assay and latex agglutination techniques in the diagnosis of deep vein thrombosis. Clin Lab Haematol 1990;12:37-42
  3. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective En- docarditis of the European Society of Cardiology (ESC). En- dorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-413
  4. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collabora- tion with the American Society of Echocardiography. Circula- tion 1997;95:1686-744
  5. Sucu M, Davutoğlu V, Ozer O, Aksoy M. Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia Region. Turk Kardiyol Dern Ars 2010;38:107-11
  6. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, et al. Guidelines on the diagnosis and manage- ment of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276-315
  7. Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Perrier A, et al. Value of D-dimer testing for the exclusion of pulmo- nary embolism in patients with previous venous thromboem- bolism. Arch Intern Med 2006;166:176-80
  8. Hirano K, Takashima S, Dougu N, Taguchi Y, Nukui T, Koni- shi H, et al. Study of hemostatic biomarkers in acute isch- emic stroke by clinical subtype. J Stroke Cerebrovasc Dis 2012;21:404-10
  9. Michiels JJ, Palareti G, de Moerloose P. Fibrin D-dimer test- ing for venous and arterial thrombotic disease. Semin Vasc Med 2005;5:311-4. 1